DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/ws4g4h/liraglutide) has announced the addition of the "Liraglutide - Comprehensive patent search" report to their offering.
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.
Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.
Pipeline Developer features:
- Comprehensive patent searching, covering the world's key territories
- Identifies patents covering molecule, formulation, process, use, combination and assay techniques
- Patent identification, categorisation and interpretation
- Grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims
- Manual filtration of patents not relevant to generic development
- Updated on a monthly basis, including changes to patent families, statuses, and litigation
- Enables fast analysis and verification by hyper-linking to crucial patent documents and national registers
Patent Categories Identified:
1. Molecular Form
2. Active Ingredient Preparation
3. Formulations & Methods Thereof
4. Related Medical Use & Administration
5. Active Ingredient Combinations
6. Analytical Methods
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information.
Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.
The Pipeline Developer report covers Liraglutide
Liraglutide indications: Treatment of type 2 diabetes mellitus, optionally in combination with Metformin and/or a sulphonylurea
Liraglutide innovator: Novo Nordisk (Victoza)
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.
For more information visit http://www.researchandmarkets.com/research/ws4g4h/liraglutide